Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine (CHEBI:71467)
Annotations: Rat: (0) Mouse: (0) Human: (0) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0)
Parent Terms Term With Siblings Child Terms
(4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid 
(5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoic acid 
(5Z,8Z,11Z,14Z,16E,18R)-18-hydroperoxyicosapentaenoic acid 
(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl group 
(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl-containing glycerolipid 
(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine 
An N-(long-chain-acyl)ethanolamine that is the ethanolamide of (5Z,8Z,11Z,14Z17Z)-eicosapentaenoic acid.
(5Z,8Z,11Z,17Z)-14,15-epoxyicosatetraenoic acid 
(5Z,8Z,14Z,17Z)-11,12-epoxyicosatetraenoic acid 
(5Z,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoic acid +  
(6E,8Z,11Z,14Z,17Z)-5-oxoicosapentaenoic acid 
(Z,Z,Z)-icosa-8,11,14-trienoylethanolamide 
1-[(11Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine 
1-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine 
1-[(9Z)-octadecenoyl]-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine 
1-hexadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-icosapentaenoyl]-sn-glycero-3-phosphocholine 
1-hexadecyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine 
1-icosanoyl-2-[(5Z,8Z,11ZZ,14Z,17Z)-eicosapentaenoyl]-sn-glycerol 
1-O-hexadecyl-2-(8-carboxyoctanoyl)-sn-glycero-3-phosphocholine 
1-octadecanoyl-2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycero-3-phosphocholine 
11-HEPE +  
12-HPEPE +  
17(18)-EpETE +  
19-HEPE 
2-[(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl]-sn-glycerol 
2-arachidonoylglycerol  
2-arachidonyl glyceryl ether 
2-hydroxylinoleic acid 
20-HEPE 
4',6,7-trihydroxyisoflavone 
5,20-diHEPE 
7,10,13,16-Docosatetraenoylethanolamine 
anandamide +   
cholesteryl (5Z,8Z,11Z,14Z,17Z-eicosapentaenoate) 
eicosa-5,8,11,14-tetraenoic acid 1,3-dihydroxypropan-2-yl ester 
ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate 
linoleoyl ethanolamide 
monascin  
N-(11Z,14Z)-eicosadienoylethanolamine 
N-(20-hydroxyarachidonoyl)ethanolamine 
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine 
N-(dodecanoyl)ethanolamine 
N-(icosanoyl)ethanolamine 
N-(octadecanoyl)ethanolamine 
N-(tetradecanoyl)ethanolamine 
N-[(5Z,11Z,14Z)-8,9-epoxyicosatrienoyl]ethanolamine 
N-[(5Z,8Z,11Z)-14,15-epoxyicosatrienoyl]ethanolamine 
N-[(5Z,8Z,14Z)-11,12-epoxyicosatrienoyl]ethanolamine 
N-[(8Z,11Z,14Z)-5,6-epoxyicosatrienoyl]ethanolamine 
oleoyl ethanolamide  
palmitoleoyl ethanolamide 
palmitoyl ethanolamide  
protectin D1 +  
saroglitazar 
timnodonoyl bioconjugate +  

Synonyms
Exact Synonyms: (5Z,8Z,11Z,14Z17Z)-N-(2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide
Related Synonyms: (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl ethanolamide ;   (5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl) ethanolamine ;   Anandamide (20:5, n-3) ;   EPEA ;   Formula=C22H35NO2 ;   InChI=1S/C22H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h3-4,6-7,9-10,12-13,15-16,24H,2,5,8,11,14,17-21H2,1H3,(H,23,25)/b4-3-,7-6-,10-9-,13-12-,16-15- ;   InChIKey=OVKKNJPJQKTXIT-JLNKQSITSA-N ;   N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)ethanolamine ;   N-cis-5,8, 11,14,17-eicosapentaenoylethanolamine ;   SMILES=CC\\C=C/C\\C=C/C\\C=C/C\\C=C/C\\C=C/CCCC(=O)NCCO ;   all-cis-eicosa-5,8,11,14,17-pentaenoyl ethanolamide ;   all-cis-icosa-5,8,11,14,17-pentaenoyl ethanolamide ;   eicosapentaenoyl ethanolamide ;   icosapentaenoyl ethanolamide
Xrefs: HMDB:HMDB0013649 ;   LIPID_MAPS_instance:LMFA08040008 "LIPID MAPS" ;   PMID:20601112 "Europe PMC" ;   PMID:20660502 "Europe PMC" ;   PMID:21562563 "SUBMITTER" ;   PMID:23168911 "Europe PMC" ;   Reaxys:7649107 "Reaxys"

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.